DPART
Pharmacokinetic study of Dihydroartemisinin-Piperaquine (DP) in HIV-infected children on EFV-, LPV/r-, or DTG-based ART and HIV-uninfected children not on ART. …
LATA
A randomised open label 2-arm, 96-week trial evaluating the efficacy, safety and acceptability of 8 weekly dual long-acting injectable antiretroviral …
D3 (Penta 21)
A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression in …
IMPAACT 2028
Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV
IMPAACT 2017
Phase 1/11 Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of oral and Long- Acting Injectable Cabotegravir and Long -Acting …
IMPAACT 2036
Phase I/II Study of the Safety, Tolerability, Pharmacokinetics, and antiviral activity of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in …
